Extended-release Buprenorphine as a Novel Low-dose Induction Strategy

Clinical trial NCT06441604 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06441604
Sponsor: Brigham and Women's Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid Use Disorder

Start date: 2025-10-27
Primary completion: 2026-06-11
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.